Cablivi

Cablivi (caplacizumab) is a medication used to manage certain blood clotting disorders. This intravenous or subcutaneous treatment is designed to help prevent severe complications related to clotting.

Cablivi is primarily used to treat acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood disorder. It works by inhibiting von Willebrand factor, which helps prevent the formation of blood clots. Patients often wonder, 'What is Cablivi used for?' and the answer lies in its ability to manage and reduce the risk of severe clotting events.

Common effects of Cablivi may include mild bleeding or bruising at the injection site. Some users might experience headaches or nausea. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Cablivi should be handled with care, especially when administered intravenously or subcutaneously. It is important to follow proper hygiene practices to prevent infection. Patients with a history of bleeding disorders should use Cablivi under medical supervision.

Cablivi may interact with other medications that affect blood clotting, such as anticoagulants. It is also important to avoid alcohol, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.